Single Ventricle Heart Disease

2

Review clinical trials related to Single Ventricle Heart Disease. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

CAMEO-FONTAN -Dapagliflozin in the Failing Fontan Circulation

The purpose of this research is to determine whether treatment with the study drug dapagliflozin for 3 months affects peripheral venous pressure at rest and during exercise in adults with failing Fontan circulation.

Participants needed: 27
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Mayo ClinicUpdated: May 6, 2026Locations: 1
Eligibility criteria

Signed informed consent prior to any study specific procedures [+5]

Type I diabetes [+14]

Status: Recruiting

Fontan Udenafil Exercise Longitudinal Assessment Trial - 2

This study will evaluate the clinical efficacy and safety of udenafil, an orally administered, potent and selective inhibitor of PDE5, versus placebo for the treatment of adolescent who have had the Fontan procedure.

Participants needed: 436
Trial details
Phase: Phase 3Age: 12-18Biological sex: AllType: InterventionalSponsor: Mezzion Pharma Co. LtdUpdated: Oct 28, 2025Locations: 40
Eligibility criteria

Males and females with Fontan physiology who are 12 to less than 19 years of age... [+3]

Height < 132 cm. [+29]